258 related articles for article (PubMed ID: 30790623)
1. Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital.
Jackson C; Ardinger C; Winter KM; McDonough JH; McCarren HS
J Pharmacol Toxicol Methods; 2019; 97():1-12. PubMed ID: 30790623
[TBL] [Abstract][Full Text] [Related]
2. Seizure suppression and neuroprotection in soman-exposed rats following delayed intramuscular treatment of adenosine A
Keith ZM; Munoz C; Acon-Chen C; Shih TM
Toxicol Appl Pharmacol; 2024 Jul; 488():116970. PubMed ID: 38777098
[TBL] [Abstract][Full Text] [Related]
3. Preventing Long-Term Brain Damage by Nerve Agent-Induced Status Epilepticus in Rat Models Applicable to Infants: Significant Neuroprotection by Tezampanel Combined with Caramiphen but Not by Midazolam Treatment.
De Araujo Furtado M; Aroniadou-Anderjaska V; Figueiredo TH; Pidoplichko VI; Apland JP; Rossetti K; Braga MFM
J Pharmacol Exp Ther; 2024 Jan; 388(2):432-450. PubMed ID: 37739807
[TBL] [Abstract][Full Text] [Related]
4. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication.
Althaus AL; McCarren HS; Alqazzaz A; Jackson C; McDonough JH; Smith CD; Hoffman E; Hammond RS; Robichaud AJ; Doherty JJ
Epilepsy Behav; 2017 Mar; 68():22-30. PubMed ID: 28109985
[TBL] [Abstract][Full Text] [Related]
5. Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.
Wu X; Kuruba R; Reddy DS
J Pharmacol Exp Ther; 2018 Nov; 367(2):302-321. PubMed ID: 30115757
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.
Lumley LA; Nguyen DA; de Araujo Furtado M; Niquet J; Linz EO; Schultz CR; Stone MF; Wasterlain CG
J Pharmacol Exp Ther; 2024 Jan; 388(2):347-357. PubMed ID: 37977809
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
Nguyen DA; Stone MF; Schultz CR; de Araujo Furtado M; Niquet J; Wasterlain CG; Lumley LA
J Pharmacol Exp Ther; 2024 Jan; 388(2):376-385. PubMed ID: 37770198
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats.
Acon-Chen C; Koenig JA; Smith GR; Truitt AR; Thomas TP; Shih TM
Toxicol Mech Methods; 2016 Jun; 26(5):378-88. PubMed ID: 27329284
[TBL] [Abstract][Full Text] [Related]
9. Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
Figueiredo TH; Aroniadou-Anderjaska V; Apland JP; Rossetti K; Braga MF
Exp Biol Med (Maywood); 2023 Apr; 248(7):612-623. PubMed ID: 37300407
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine stops benzodiazepine-refractory nerve agent-induced status epilepticus.
McCarren HS; Arbutus JA; Ardinger C; Dunn EN; Jackson CE; McDonough JH
Epilepsy Res; 2018 Mar; 141():1-12. PubMed ID: 29414381
[TBL] [Abstract][Full Text] [Related]
11. Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine.
Spampanato J; Bealer SL; Smolik M; Dudek FE
J Pharmacol Exp Ther; 2020 Oct; 375(1):59-68. PubMed ID: 32873622
[TBL] [Abstract][Full Text] [Related]
12. The K
Barker BS; Spampanato J; McCarren HS; Berger K; Jackson CE; Yeung DT; Dudek FE; McDonough JH
Neuroscience; 2021 May; 463():143-158. PubMed ID: 33836243
[TBL] [Abstract][Full Text] [Related]
13. Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam.
Marrero-Rosado B; de Araujo Furtado M; Schultz CR; Stone M; Kundrick E; Walker K; O'Brien S; Du F; Lumley LA
Epilepsia; 2018 Dec; 59(12):2206-2218. PubMed ID: 30368799
[TBL] [Abstract][Full Text] [Related]
14. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.
Lumley LA; Marrero-Rosado B; Rossetti F; Schultz CR; Stone MF; Niquet J; Wasterlain CG
Epilepsia Open; 2021 Dec; 6(4):757-769. PubMed ID: 34657398
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Organophosphate Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage.
Singh T; Ramakrishnan S; Wu X; Reddy DS
J Pharmacol Exp Ther; 2024 Jan; 388(2):313-324. PubMed ID: 37770202
[TBL] [Abstract][Full Text] [Related]
16. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy.
Aroniadou-Anderjaska V; Figueiredo TH; Apland JP; Braga MF
Neurobiol Dis; 2020 Jan; 133():104406. PubMed ID: 30798006
[TBL] [Abstract][Full Text] [Related]
17. Rational polytherapy in the treatment of cholinergic seizures.
Niquet J; Lumley L; Baldwin R; Rossetti F; Suchomelova L; Naylor D; Estrada IBF; Schultz M; Furtado MA; Wasterlain CG
Neurobiol Dis; 2020 Jan; 133():104537. PubMed ID: 31454548
[TBL] [Abstract][Full Text] [Related]
18. A novel genetically modified mouse seizure model for evaluating anticonvulsive and neuroprotective efficacy of an A
Shih TM
Toxicol Appl Pharmacol; 2023 Apr; 464():116437. PubMed ID: 36849019
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
[TBL] [Abstract][Full Text] [Related]
20. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
Reddy DS
J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
